Synthetic Biology-Based Therapeutics Summit

Conference themes
Investigate Foundational Technologies, Applications, and Manufacturing Strategies to Create Advanced, Controllable Drugs at the Only Technical Meeting to Explore the Therapeutic Applications of Synthetic Biology.

This year, the synthetic biology market has seen fledgling companies rise to IPO smashing power players, as the demand for high-quality, engineered biomolecules and controllable therapeutics grows exponentially.

Professional congress organizer (PCO)
Hanson Wade

Notes
Brochure: https://go.evvnt.com/853527-3?pid=4832

Speakers: Aaron Cooper, Director Synthetic Biology, ArsenalBio, Jak Knowles, CEO, Affini-T Therapeutics, Sheila Mikhail, CEO, AskBio and more

https://go.evvnt.com/853527-2?pid=4832

Ms. Georgina Fitzgerald